Avatrombopag is an orally administered, small-molecule thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease and chronic immune thrombocytopenia. By binding… Read more














Avatrombopag is an orally administered, small-molecule thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease and chronic immune thrombocytopenia. By binding to the thrombopoietin receptor, this medication stimulates the proliferation and differentiation of megakaryocytes to increase platelet production. Laboratories require high-quality reference standards, including the active pharmaceutical ingredient, to support rigorous analytical testing and quality control. Impurity profiling is critical during the drug development lifecycle, where specific impurities, degradation products, and synthetic intermediates are used to validate analytical methods and ensure regulatory compliance. Furthermore, stable isotope labelled compounds are essential tools in mass spectrometry-based bioanalytical studies, allowing for accurate quantification and tracking. These specialized reference materials enable researchers and quality control scientists to maintain the consistency, safety, and efficacy of pharmaceutical products throughout the manufacturing and approval processes.